Study ID: TV1106-IMM-30022 | 2014-002736-13
Study Title
- Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Teva Identifier
- TV1106-IMM-30022 | 2014-002736-13
ClinicalTrials.gov Identifier
- NCT02410356
Study Status
- Terminated
Trial Condition(s)
- Growth Hormone Deficiency
Interventions
- Drug: TV-1106 | Drug: dGH
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- April 30, 2015 - April 30, 2016
Phase
- Phase 3
Study Type
Interventional